2025 COMB丨Professor Jiayu Wang: Balancing Individualized Treatment and Liver Function Preservation in Breast Cancer Liver Metastases
Editor’s Note: Breast cancer liver metastases represent a major clinical challenge, requiring treatment strategies that balance anti-tumor efficacy with protection of liver function. At the 8th Conference on Oncology Precision…
Professor Robert Negrin, ASH President-Elect: Immunoregulatory Mechanisms to Improve Transplant Outcomes
Editor’s Note: The 13th Ludaopei Hematology Academic Conference, jointly organized by the Beijing Health Promotion Association and the Guangzhou Hongmian Tumor and Rare Disease Public Welfare Foundation and hosted by…
Professor Qing Zou: Advancing Comprehensive Therapy and “Full-Course Management” Systems for Urologic Malignancies
In recent years, the management of urologic malignancies—including kidney cancer and bladder cancer—has been moving toward a new era of comprehensive care, innovative treatments, multidisciplinary collaboration (MDT), and multi-technology integration. The goal is to build a “full-course management” system that maximizes clinical benefit for patients by combining advances from across specialties. At the 2025 Pujiang Uro-Oncology Conference, Professor Qing Zou of Jiangsu Cancer Hospital shared the latest developments in the diagnosis and treatment of representative urologic tumors such as kidney cancer and non–muscle-invasive bladder cancer (NMIBC). He also discussed the implementation of innovative technologies, MDT collaboration, and the experience of building a full-course management system.
Professor Yue Lu: Second Allogeneic Hematopoietic Stem Cell Transplantation for Post-Transplant Relapse in Acute Leukemia
Editor’s Note: On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was successfully held in Beijing, jointly organized by the Beijing Health Promotion Association and the Guangzhou Kapok Oncology…
Professor Junfang Yang: Clinical Research and Practice of CD7 CAR-T Therapy in Relapsed/Refractory Hematologic Malignancies
On August 22–23, 2025, the 13th Lu Daopei Hematology Conference was held in Beijing, co-hosted by the Beijing Health Promotion Association and the Guangzhou Hongmian Oncology & Rare Disease Public…
2025 COMB丨Professor Peng Yuan: Multi-Gene Testing Drives Personalized Treatment and Illuminates a New Era in Precision Breast Cancer Care
Editor’s Note: The 8th Conference on Oncology Precision Medicine and the 11th Conference on Individualized Therapy for Breast Cancer were recently held in Beijing, jointly organized by the Beijing Breast…
Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer
Editor’s Note: Endocrine resistance is one of the major challenges in the treatment of HR+/HER2- breast cancer. At the 8th Conference on Oncology Precision Medicine and the 11th Conference on…